INmune Bio, Inc.

( )
INMB PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -0.17%135.570.0%$895.14m
AMGNAmgen, Inc. 0.36%253.951.5%$855.01m
GILDGilead Sciences, Inc. 0.00%64.471.0%$544.83m
VRTXVertex Pharmaceuticals, Inc. 0.32%270.501.9%$489.26m
REGNRegeneron Pharmaceuticals, Inc. 0.05%683.772.6%$434.75m
ILMNIllumina, Inc. 1.76%247.853.3%$318.97m
NVAXNovavax, Inc. -1.08%46.5675.7%$255.64m
BIIBBiogen, Inc. 0.00%204.221.8%$232.70m
BNTXBioNTech SE 0.53%158.990.0%$212.11m
SNSSSunesis Pharmaceuticals, Inc. 0.00%2.100.7%$146.80m
EXASEXACT Sciences Corp. 2.21%50.9617.7%$131.02m
TECHBio-Techne Corp. 0.00%365.324.5%$100.31m
TXG10X Genomics, Inc. 0.00%47.350.0%$95.11m
BMRNBioMarin Pharmaceutical, Inc. 0.00%78.864.2%$94.54m
CRSPCRISPR Therapeutics AG 1.87%56.260.6%$81.90m

Company Profile

INmune Bio, Inc. Is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprograms the immune system to fight cancer and Alzheimer’s disease. Its products include pipeline, INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate. The company was founded by Mark Lowdell in September 2015 and is headquartered in Boca Raton, FL.